Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Behav Brain Res ; 209(1): 93-8, 2010 May 01.
Article in English | MEDLINE | ID: mdl-20096733

ABSTRACT

The objective of the present study is to investigate the effects of single and simultaneous lesions of the noradrenergic and serotonergic pathways (NA-X, 5-HT-X and XX, respectively) by intracerebroventricular administration of selective neurotoxins N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine-HCl (DSP-4) and 5,7-dihydroxytryptamine (5,7-DHT) on anxiety-like behavior in rats. To evaluate the effects of the various lesions, animals were tested in elevated plus-maze (EPM) and light-dark (LD) paradigms. In EPM, single lesions produced strong, statistically significant increase (p<0.001) of both time spent in the open arms (OT) and number of entries into the open arms (OE) compared to sham-lesioned animals. Simultaneous lesion further strengthened this anxiolytic effect causing an approximate 500% elevation of OT compared to sham-lesioned animals. In LD, 5-HT lesion caused a significant (p<0.05) increase in both light movement time and light horizontal activity parameters compared to intact, sham, and NA-lesioned groups. Neither of the lesions caused any change in the spontaneous locomotor activity of the animals up to 15min as measured in activity meter. These findings suggest that single and simultaneous lesions of 5-HT- and NA-pathways modify anxiety-related state of experimental animals to different extents and these modifications alter the behavior of animals differently in the two models used: NA-X and 5-HT-X reduce open space anxiety-like behavior and XX further strengthens this effect in the EPM, while only 5-HT-X is resulting in reduced bright-space anxiety-like behavior leaving the performance of NA-X and XX animals unchanged.


Subject(s)
Adaptation, Physiological/physiology , Anxiety/etiology , Exploratory Behavior/physiology , Norepinephrine/metabolism , Serotonin/metabolism , Spatial Behavior/physiology , 5,7-Dihydroxytryptamine/adverse effects , 5,7-Dihydroxytryptamine/pharmacology , Adaptation, Physiological/drug effects , Adrenergic Agents/adverse effects , Adrenergic Agents/pharmacology , Adrenergic Uptake Inhibitors/pharmacology , Animals , Benzylamines/adverse effects , Benzylamines/pharmacology , Chromatography, High Pressure Liquid/methods , Desipramine/pharmacology , Desipramine/therapeutic use , Disease Models, Animal , Fluoxetine/pharmacology , Fluoxetine/therapeutic use , Injections, Intraventricular/methods , Male , Maze Learning/drug effects , Motor Activity/drug effects , Rats , Rats, Sprague-Dawley , Serotonin Agents/adverse effects , Serotonin Agents/pharmacology , Selective Serotonin Reuptake Inhibitors/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...